| Host: |
Rabbit |
| Applications: |
WB/ELISA |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Clonality: |
Monoclonal |
| Clone ID: |
S5MR |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.02% Sodium Azide, 0.05% BSA, 50% Glycerol, pH 7.3. |
| Purification: |
Affinity purification |
| Concentration: |
Lot specific |
| Dilution Range: |
WB:1:1000-1:2000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
AGTR2 |
| Gene ID: |
186 |
| Uniprot ID: |
AGTR2_HUMAN |
| Immunogen Region: |
264-363 |
| Specificity: |
A synthetic peptide corresponding to a sequence within amino acids 264-363 of human AGTR2 (P50052). |
| Immunogen Sequence: |
AFIICWLPFHVLTFLDALAW MGVINSCEVIAVIDLALPFA ILLGFTNSCVNPFLYCFVGN RFQQKLRSVFRVPITWLQGK RESMSCRKSSSLREMETFVS |
| Tissue Specificity | In adult, highly expressed in myometrium with lower levels in adrenal gland and fallopian tube. Expressed in the cerebellum. Very highly expressed in fetal kidney and intestine. |
| Function | Receptor for angiotensin II, a vasoconstricting peptide. Signals primarily via a non-canonical G-protein- and beta-arrestin independent pathways. Cooperates with MTUS1 to inhibit ERK2 activation and cell proliferation. |
| Protein Name | Type-2 Angiotensin Ii ReceptorAngiotensin Ii Type-2 ReceptorAt2 Receptor |
| Database Links | Reactome: R-HSA-375276Reactome: R-HSA-418594 |
| Cellular Localisation | Cell MembraneMulti-Pass Membrane Protein |
| Alternative Antibody Names | Anti-Type-2 Angiotensin Ii Receptor antibodyAnti-Angiotensin Ii Type-2 Receptor antibodyAnti-At2 Receptor antibodyAnti-AGTR2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
